ghk-cu vs glow KLOW — The Peptide Blend Dilemma Glow TB-500 + BPC-157 +
Description
Competing interests The authors declare that they have no conflict of interest
Incomplete voiding results in residual urine or urinary stasis, which can lead to an increased risk of urinary tract infection
Blood (2017) 130:121
A.RuigmezA
Administered in cycles of 3-6 daily injections, patients treated with BPC-157 report up to 90 % pain reduction lasting months to years after a single cycle
A small amount of vitamin B12 is included in this compounded formulation
